Randall A. Lipps net worth and biography

Randall Lipps Biography and Net Worth

CEO of Omnicell
Randall Lipps is Chairman, President, Chief Executive Officer, and founder of Omnicell. Under his leadership, Omnicell has grown from offering a single product to delivering the most comprehensive portfolio of medication management solutions across the continuum of care. The company is now building on its success in advanced automation, data intelligence, and expert services to fulfill its vision of the Autonomous Pharmacy.

Mr. Lipps founded Omnicell in 1992 after observing how inefficiently medical supplies were managed when his daughter was hospitalized at birth. Inspired by his work in airline industry operations and logistics, he sought to enable better management of supplies and medications in order to improve patient care.

Omnicell became a publicly traded company in August 2001, and today the company’s award-winning solutions are used in over 5,000 hospitals throughout the world and in over 40,000 institutional and retail pharmacies. Omnicell has been recognized as one of the top 150 Silicon Valley companies, as measured by market capitalization, by the San Jose Mercury News.

In 2014 Mr. Lipps was elected to the Bellwether League Hall of Fame. The Bellwether League is an industry organization that honors healthcare supply chain innovators, pioneers, and visionaries.

Mr. Lipps has made giving back to the community a priority at Omnicell, and the company has contributed funds and other assistance in response to natural disasters and to support other causes such as Mercy Ships, which delivers free healthcare to some of the poorest people in the world. Mr. Lipps and his wife, Kathy, have focused their own philanthropy on poverty, nursing and public education, pharmacy research, youth groups, and local community efforts.

What is Randall A. Lipps' net worth?

The estimated net worth of Randall A. Lipps is at least $15.36 million as of August 16th, 2022. Mr. Lipps owns 302,049 shares of Omnicell stock worth more than $15,356,171 as of December 3rd. This net worth evaluation does not reflect any other assets that Mr. Lipps may own. Additionally, Mr. Lipps receives a salary of $2,440,000.00 as CEO at Omnicell. Learn More about Randall A. Lipps' net worth.

How old is Randall A. Lipps?

Mr. Lipps is currently 65 years old. There are 5 older executives and no younger executives at Omnicell. Learn More on Randall A. Lipps' age.

What is Randall A. Lipps' salary?

As the CEO of Omnicell, Inc., Mr. Lipps earned a total compensation package of $8,437,413.00 in 2021. Mr. Lipps earned a salary of $768,123.00, stock awards of $6,001,550.00, non-equity compensation of $1,624,740.00, and other compensation of $43,000.00. Learn More on Randall A. Lipps' salary.

How do I contact Randall A. Lipps?

The corporate mailing address for Mr. Lipps and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (650) 251-6100 and via email at [email protected] Learn More on Randall A. Lipps' contact information.

Has Randall A. Lipps been buying or selling shares of Omnicell?

Randall A. Lipps has not been actively trading shares of Omnicell in the last ninety days. Most recently, Randall A. Lipps sold 13,000 shares of the business's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $111.04, for a transaction totalling $1,443,520.00. Following the completion of the sale, the chief executive officer now directly owns 302,049 shares of the company's stock, valued at $33,539,520.96. Learn More on Randall A. Lipps' trading history.

Who are Omnicell's active insiders?

Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.

Are insiders buying or selling shares of Omnicell?

During the last year, insiders at the sold shares 8 times. They sold a total of 55,817 shares worth more than $6,738,669.58. The most recent insider tranaction occured on November, 28th when EVP Scott Peter Seidelmann sold 1,793 shares worth more than $92,267.78. Insiders at Omnicell own 2.8 % of the company. Learn More about insider trades at Omnicell.

Information on this page was last updated on 11/28/2022.

Randall A. Lipps Insider Trading History at Omnicell

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2022Sell13,000$111.04$1,443,520.00302,049View SEC Filing Icon  
12/8/2020Sell17,500$110.56$1,934,800.00152,116View SEC Filing Icon  
11/23/2020Sell15,000$105.34$1,580,100.00152,116View SEC Filing Icon  
11/20/2020Sell2,400$105.01$252,024.00152,116View SEC Filing Icon  
11/4/2020Sell11,435$89.59$1,024,461.65152,116View SEC Filing Icon  
9/15/2020Sell1,400$75.01$105,014.00152,116View SEC Filing Icon  
7/29/2020Sell3,718$75.15$279,407.70152,116View SEC Filing Icon  
4/3/2020Sell5,000$66.11$330,550.00159,266View SEC Filing Icon  
1/7/2020Sell24,000$81.41$1,953,840.00116,466View SEC Filing Icon  
11/21/2019Sell20,902$78.75$1,646,032.50128,487View SEC Filing Icon  
10/25/2019Sell1,172$78.00$91,416.00128,487View SEC Filing Icon  
10/21/2019Sell25,926$78.03$2,023,005.78128,487View SEC Filing Icon  
10/18/2019Sell5,000$76.04$380,200.00140,506View SEC Filing Icon  
7/25/2019Sell5,000$70.30$351,500.00140,506View SEC Filing Icon  
4/29/2019Sell65,161$63.77$4,155,316.97View SEC Filing Icon  
4/29/2019Sell24,282$79.01$1,918,520.82View SEC Filing Icon  
2/22/2019Sell20,000$85.54$1,710,800.00194,793View SEC Filing Icon  
12/18/2018Sell9,482$63.89$605,804.98165,025View SEC Filing Icon  
6/18/2018Sell439$52.00$22,828.00211,323View SEC Filing Icon  
3/6/2018Sell8,186$44.21$361,903.06224,206View SEC Filing Icon  
9/1/2017Sell10,625$52.00$552,500.00View SEC Filing Icon  
8/1/2017Sell40,000$49.76$1,990,400.00196,551View SEC Filing Icon  
7/28/2017Sell37,500$46.00$1,725,000.00196,551View SEC Filing Icon  
6/19/2017Sell31,527$42.87$1,351,562.49196,551View SEC Filing Icon  
6/5/2017Sell9,900$43.00$425,700.00208,982View SEC Filing Icon  
4/25/2017Sell18,200$41.00$746,200.00208,982View SEC Filing Icon  
8/11/2016Sell37,425$37.37$1,398,572.25192,325View SEC Filing Icon  
2/11/2016Sell40,000$27.81$1,112,400.00204,705View SEC Filing Icon  
8/2/2013Sell25,000$22.50$562,500.00View SEC Filing Icon  
7/19/2013Sell5,080$21.00$106,680.00View SEC Filing Icon  
6/28/2013Sell25,000$20.00$500,000.00View SEC Filing Icon  
6/18/2013Sell66,378$19.10$1,267,819.80View SEC Filing Icon  
See Full Table

Randall A. Lipps Buying and Selling Activity at Omnicell

This chart shows Randall A Lipps's buying and selling at Omnicell by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Omnicell Company Overview

Omnicell logo
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Read More

Today's Range

Now: $50.84
Low: $50.05
High: $52.65

50 Day Range

MA: $66.96
Low: $46.24
High: $90.03

2 Week Range

Now: $50.84
Low: $46.19
High: $185.28

Volume

703,772 shs

Average Volume

527,035 shs

Market Capitalization

$2.25 billion

P/E Ratio

49.84

Dividend Yield

N/A

Beta

0.91
Millionaire Investor Reveals: “How I Made My Second Fortune… By Avoiding 99% of Stocks”
Buy this small group of unique stocks… never sell them… and make all the money you need… No matter what happens in the market.

Revealed here: the name and ticker of the #1 stock.
>>>
pixel